Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 296

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Diagnosis and Detection of Pancreatic Cancer

Chu, Linda C., Goggins, Michael G., Fishman, Elliot K.·2017·The Cancer Journal

Abstract

Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected pancreatic cancer and is usually reserved for equivocal cases. Both computed tomography and MR are highly sensitive in the detection of pancreatic cancer, with up to 96% and 93.5% sensitivity, respectively. Computed tomography is superior to MR in the assessment of tumor resectability, with accuracy rates of up to 86.8% and 78.9%, respectively. Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. The results of these promising techniques need to be validated in larger clinical studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ppo.0000000000000290

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Research works printed but not linked: 17

  1. 2003, Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma, Am J Gastroenterol, 98, 2679, 10.1111/j.1572-0241.2003.08727.x · doi:10.1111/j.1572-0241.2003.08727.x
  2. 2008, Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI, Acta Radiol, 49, 490, 10.1080/02841850802014602 · doi:10.1080/02841850802014602
  3. 2010, Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI, Am J Gastroenterol, 105, 1870, 10.1038/ajg.2010.87 · doi:10.1038/ajg.2010.87
  4. 2014, Quantified ADC histogram analysis: a new method for differentiating mass-forming focal pancreatitis from pancreatic cancer, Acta Radiol, 55, 785, 10.1177/0284185113509264 · doi:10.1177/0284185113509264
  5. 2013, Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0 T, Magn Reson Imaging, 31, 524, 10.1016/j.mri.2012.09.006 · doi:10.1016/j.mri.2012.09.006
  6. 2011, Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging, J Dig Dis, 12, 401, 10.1111/j.1751-2980.2011.00517.x · doi:10.1111/j.1751-2980.2011.00517.x
  7. 2017, The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer, Pancreatology, 17, 451, 10.1016/j.pan.2017.03.001 · doi:10.1016/j.pan.2017.03.001
  8. 2010, Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer, J Gastrointest Surg, 14, 1151, 10.1007/s11605-010-1207-x · doi:10.1007/s11605-010-1207-x
  9. 2015, Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors, Pancreas, 44, 655, 10.1097/MPA.0000000000000313 · doi:10.1097/mpa.0000000000000313
  10. 2013, FDG-PET/CT–based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy, Cancer Imaging, 13, 423
  11. 2014, The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma, Hepatogastroenterology, 61, 2102
  12. 2011, Endoscopic ultrasound in cystic pancreatic lesions: operator training needs to be improved, EUS-guided sampling should be standardized, and decision-making should be multidisciplinary and evidence-based, Endoscopy, 43, 557, 10.1055/s-0030-1256614 · doi:10.1055/s-0030-1256614
  13. 2015, EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1, Gastrointest Endosc, 81, 159, 10.1016/j.gie.2014.09.037 · doi:10.1016/j.gie.2014.09.037
  14. 2017, Cinematic rendering in CT: a novel, lifelike 3D visualization technique, AJR Am J Roentgenol, 209, 370, 10.2214/AJR.17.17850 · doi:10.2214/ajr.17.17850
  15. 2017, MDCT angiography with 3D rendering: a novel cinematic rendering algorithm for enhanced anatomic detail, AJR Am J Roentgenol, 209, 309, 10.2214/AJR.17.17903 · doi:10.2214/ajr.17.17903
  16. A fixed-point model for pancreas segmentation in abdominal CT scans
  17. Deep supervision for pancreatic cyst segmentation in abdominal CT scans

Cited by

See all 296

Metadata

Authors
Chu, L. C., Goggins, M. G., & Fishman, E. K.
Venue
The Cancer Journal
Published
2017-11
Volume
23
Issue
6
Pages
333-342
ISSN
  • 1528-9117 (ISSN-L)
  • 1540-336X
OpenAlex
W2770438853
Cited by
296
References
76
FWCI
8.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnosis and Detection of Pancreatic Cancer. https://app.cochat.ai/papers/10.1097/ppo.0000000000000290
The paper
Chu, L. C., Goggins, M. G., & Fishman, E. K. (2017). Diagnosis and Detection of Pancreatic Cancer. The Cancer Journal. https://doi.org/10.1097/ppo.0000000000000290

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.